Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pearl Therapeutics
Pearl Therapeutics
AstraZeneca two-in-one drug succeeds in lung disease test
Yahoo/Reuters
Wed, 03/18/15 - 08:18 am
AstraZeneca
PT003
Pearl Therapeutics
COPD
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
AstraZeneca - Conducting Major Acquisitions
Seeking Alpha
Tue, 06/11/13 - 03:58 pm
AstraZeneca
M&A
GSK
Novartis
Omthera
Pearl Therapeutics
Pfizer
AstraZeneca to Pay Up to $1.15 Billion for Pearl
Bloomberg
Mon, 06/10/13 - 06:01 am
M&A
Pearl Therapeutics
AstraZeneca
PhRMA's COPD pipeline report spotlights blockbuster hopefuls
Fierce Biotech
Mon, 02/6/12 - 11:24 am
PhRMA
COPD
GSK
Theravance
Novartis
Pearl Therapeutics
Osiris
Elevation Pharmaceuticals
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Blueprint Medicines
Cerulean
Cerenis Therapeutics
Epizyme
Forma Therapeutics
Intrexon
Merrimack Pharmaceuticals
f-star
Pfenex
Pearl Therapeutics
Reata
Selecta
Rib-X Pharmaceuticals
Tesaro
Theraclone
Pearl moves lung drug into Phase IIb trial
Bizjournals.com
Tue, 03/30/10 - 09:21 am
Pearl Therapeutics
COPD